Association Between Gastroesophageal Reflux Disease and Chronic Respiratory Symptoms: A Systematic Review of Recent Clinical Evidence and Therapeutic Implications
Abstract
Gastroesophageal reflux disease (GERD) is increasingly recognized as a potential contributor to chronic respiratory symptoms, yet its role in the pathogenesis and management of such conditions remains underexplored. This systematic review aimed to evaluate the association between GERD and respiratory manifestations including chronic cough, asthma, chronic rhinosinusitis, and chronic obstructive pulmonary disease (COPD). A comprehensive search was conducted across PubMed, Scopus, Web of Science, and Embase for studies published between January 2020 and April 2025. Six eligible studies, including randomized controlled trials and prospective observational studies, were analyzed. The findings demonstrate a consistent relationship between GERD and respiratory symptoms, with acid-suppressive therapies - particularly proton pump inhibitors (PPIs) and potassium-competitive acid blockers (P-CABs) - leading to symptomatic improvement in several patient populations. Non-pharmacological interventions such as diaphragmatic breathing also showed clinical benefit in GERD-induced chronic cough. Pediatric evidence, though limited, supported the role of GERD management in improving asthma control. Risk of bias across studies was generally low to moderate. While causality cannot be definitively established, the cumulative evidence highlights the importance of considering GERD in patients with refractory respiratory complaints. Integrating GERD assessment and treatment into respiratory care may…
How strong is the evidence?
Evidence Hub reads this as a systematic review, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study
- Treatment and prognostic factors for long-term outcome in patients with anti-N-Methyl-D-Aspartate (NMDA) receptor encephalitis: a cohort study
- Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study
- Postsurgical prescriptions for opioid naive patients and association with overdose and misuse: retrospective cohort study
- Ethnic and socioeconomic differences in SARS-CoV-2 infection: prospective cohort study using UK Biobank
- Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort study
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.